pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Professor uses his own thymic cancer journey to teach medical students about real-world oncology

Sep 16, 2026·read at STAT ↗Positive

David Elkowitz, a professor of pathology and laboratory medicine at Hofstra/Northwell, writes about how his personal battle with thymic cancer shapes his teaching.

He now brings his own case into first-year curricula, allowing students to meet the patient, the family and the oncologist, and to see the emotional and decision-making aspects of cancer care.

Elkowitz argues that linking scientific concepts to a real person makes the learning experience more humanistic and prepares future physicians for the realities of patient care.

Diagnosed in 2017 with a rare, aggressive thymic tumor, he uses his ongoing treatment journey as a living example for students.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: How my cancer diagnosis changed the way I train physicians”

read at STAT ↗
1,138 words · retrieved 30m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
JOURNEY2Ultragenyx Pharmaceutical Inc.2UNIQUE
topics
Oncology16Rare Disease2Alzheimer's DiseaseVaccine

related stories

  • 19h agoSionna says good-bye to 46% of staffers, including execBioSpace
  • Aug 25After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platformFierce Biotech
  • Aug 20Contrasting legal decisions on gender-affirming careSTAT
  • Jul 16Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical expertsSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive